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Abstract 
Supplemented protein or specific amino acids (AA) are proposed to help animals combat  1 
infection and inflammation. The current study investigates whole body and splanchnic tissue 2 
metabolism in response to a lipopolysaccharide (LPS) challenge with or without a 3 
supplement of six AA (cysteine, glutamine, methionine, proline, serine and threonine).  Eight 4 
sheep were surgically prepared with vascular catheters across the gut and liver. On two 5 
occasions 4 sheep were infused through the jugular vein for 20 h with either saline or LPS 6 
from E.coli (2 ng/kg BW/min) in a random order plus saline into the mesenteric vein;  the 7 
other 4 sheep were treated with saline or LPS via the jugular vein plus saline or 6 AA  infused 8 
into the mesenteric vein. Whole body AA irreversible loss rate (ILR) and tissue protein 9 
metabolism were m nitored by infusion of [ring-
2
H2]phenylalanine. LPS increased (P<0.001) 10 
ILR (+17%,), total plasma protein synthesis (+14%) and lymphocyte protein synthesis (+386%)  11 
but decreased albumin synthesis (-53%, P=0.001) with no effect of AA infusion. Absorption 12 
of dietary AA was not reduced by LPS, except for glutamine. LPS increased hepatic removal 13 
of leucine, lysine, glutamine and proline. Absolute hepatic extraction of supplemented AA 14 
increased but, except for glutamine, this was less than the amount infused. This increased 15 
net appearance across the splanchnic bed restored arterial concentrations of  five AA to, or 16 
above, values for the saline-infused period.  Infusion of key AA does not appear to alter the 17 
acute period of endotoxaemic response, but may have benefits for the chronic or recovery 18 
phases.   19 
 20 
Abbreviations: AA, amino acids; DM dry matter; FSR, factional synthesis rate; ILR, irreversible 21 
loss rate; LPS, lipopolysaccharide; PDV, portal-drained viscera; REML, residual maximum 22 
likelihood  23 
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Introduction 24 
 Infection or inflammation cause marked responses in amino acid (AA) and protein 25 
metabolism. These include alterations in plasma AA concentrations, with many decreased
(1-
26 
3)
, plus accompanying changes in whole body AA irreversible loss rates (ILR)
(1,3,4)
. These 27 
responses probably reflect complex interactions between the immune system and key 28 
regulatory organs. For example, lowered AA plasma concentrations may result from reduced 29 
net absorption, either from inhibition of intake that accompanies inflammation and sepsis
(5)
, 30 
or  increased oxidation by the portal-drained viscera (PDV), as observed with certain gastro-31 
intestinal infections
(6)
. Alternatively, demands within specific tissues can increase removal of 32 
AA from the blood circulation to support synthesis of either additional proteins or specific 33 
metabolites. For example, manufacture of positive acute phase proteins  increases liver 34 
utilisation of essential AA
(4)
, especially phenylalanine
(7)
, while elevated hepatic glucose 35 
synthesis during major stress
(8)
 elevates metabolism of glucogenic AA, although this is not 36 
always observed
(4)
. Similarly, production of additional glutathione to provide anti-oxidant 37 
protection adjacent to sites of inflammation and pro-oxidant activity can alter demand for 38 
cysteine
(9)
. Furthermore, activation of the immune system elevates net use of AA to support 39 
proliferative responses associated with infection or surgery
(10)
, and also increase hepatic use 40 
of glutamine
(4)
, a known regulator of intermediary metabolism
(11)
.  While some of these 41 
needs are general and require most AA, as in the case of cellular proliferation, other 42 
reactions will be restricted to one, or just a few, AA and this will leave the remainder in 43 
disproportionate excess and lead to their disposal as urea and lead to the net nitrogen losses 44 
characteristic of inflammation and sepsis
(12)
.   45 
 Reduced plasma AA during infection or inflammation can be offset by either 46 
additional protein or AA supply
(13)
 but the quantities required differ between AA
(3)
 and 47 
between type and magnitude of the challenge
(2)
.  The effectiveness of such approaches has 48 
been demonstrated in septic rodents, where a cocktail of AA reduces the severity of the 49 
challenge and enhances the rate of recovery
(14)
. Future nutritional strategies to help combat 50 
the deleterious effects of infection and inflammation and aid recovery require knowledge of 51 
both  the absolute demands for specific AA
(3)
, and where in the body these requirements 52 
arise. The effectiveness of targeted intervention in sheep, based on previous kinetic 53 
quantification of AA demands during the acute phase of an inflammatory challenge
(3)
, is 54 
addressed in the current study. The focus is on splanchnic tissue metabolism, with 55 
consequences on absorption, liver-related protein metabolism and net AA supply to 56 
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peripheral tissues.   This was tested with a cocktail of six AA, based on information gained 57 
from an earlier study
(3)
. Three (methionine, serine and threonine) were chosen because the 58 
ILR through plasma decreased markedly in response to LPS
(3)
, suggestive of a deficient supply 59 
during endotoxaemia. Cysteine has been reported as beneficial for septic rats
(14)
  and LPS-60 
challenged pigs
(15)
 but showed no change in ILR in the previous sheep study
(3)
. Also included 61 
was proline, which showed similar responses cysteine with no effects on ILR but marked 62 
decreases in plasma concentration under an LPS challenge
(3)
. The final AA in the cocktail was 63 
glutamine, supplementation of which is often used in clinical situations
(16)
 and exhibits 64 
increased turnover during cancer
(17)
 and endotoxin challenge
(3)
.   For all these AA, the 65 
amounts infused were based on the product of their ILR and the fractional reduction in 66 
plasma concentration as observed under similar experimental conditions previously
(3)
.  67 
 68 
Materials and Methods 69 
 70 
Sheep and diets 71 
 All procedures were approved by the Ethical Review Committee of the Rowett 72 
Institute of Nutrition and Health and conformed to UK legislation under the Animals 73 
(Scientific Procedures) Act 1986.  Suffolk cross lambs (n=8, 2 females, 6 castrate males; 12-16 74 
months old, 37-54 kg live weight) were prepared with silicone rubber catheters in the aorta, 75 
mesenteric vein, portal vein and hepatic vein
(18)
. During the 2 week recovery period from 76 
surgery the sheep offered a mixed roughage–concentrate diet with the following 77 
composition, g/kg as fed (2 x 500 g/d as fed: hay 500, barley 300, molasses 100, fishmeal 90, 78 
vitamin and mineral mix 10; 830 g DM/kg; 21.3 gN/kg DM, 11.0 MJ metabolisable energy/kg 79 
DM) at an estimated 1.0-1.3 x energy maintenance based on metabolic BW (kg
0.75
). 80 
Subsequently they were acclimatised over 1 week to metabolism crates, with the daily feed 81 
provided as 24 hourly portions,  and then allocated to treatments when a temporary 82 
polyvinyl catheter was inserted into the jugular vein
(18)
.   83 
  84 
At treatment allocation, the sheep (n=8) were divided between two groups, 85 
balanced for gender and weight. Within each group the sheep were measured on two 86 
experimental days,  7 days apart. For Group A (n=4) the two infusion days involved either  87 
Page 4 of 43
Cambridge University Press
British Journal of Nutrition
For Review Only
5 
 
sterile 0.15 M sodium chloride (control) infused into both the jugular vein (15 g/h) and 88 
mesenteric vein (40 g/h) for 20 h while for the other experimental day the jugular vein 89 
infusion  (15g/d)  involved lipopolysaccharide (LPS; from E. coli 155, serotype 055:B5, 2 90 
ng/min per kg BW) as described previously
(3)
.  For Group B (n=4), one experimental day  was 91 
identical to the control procedure used for Group A while the other experimental day 92 
involved  a jugular vein infusion of LPS, identical to Group A, plus a sterile mixture of AA into 93 
the mesenteric vein (40 g/h). The order of infusions (saline versus LPS, with or without AA) 94 
was randomised between sheep. Therefore, all 8 sheep received a control (saline) jugular 95 
infusion, while 4 received LPS as a treatment and 4 received LPS plus AA. The amounts for 96 
each of the AA infused were calculated from the product of their ILR and the fractional 97 
decrease in arterial concentration from control value in response to a similar dose of LPS, 98 
both as reported previously
(3)
.   For sheep with a body weight of 50 kg, the concentrations of 99 
AA-N in the supplement were cysteine (68 mM), glutamine (320 mM), methionine (38 mM), 100 
proline (64 mM), serine (124 mM) and threonine (138 mM) dissolved in 0.15 M sodium 101 
chloride. For sheep of other weight the concentration of the infusate was adjusted based on 102 
BW
0.75
.  103 
Just prior to the start of each 20 h infusion period a background blood sample was 104 
taken for evaluation of clinical parameters (including blood haemoglobin, plasma albumin, 105 
white cell count and cell type distribution) and determination of blood and plasma dry 106 
matter (by freeze-drying, each in triplicate). In order to measure plasma flow across the 107 
splanchnic tissues sterile sodium p-aminohippurate (0.1 M prepared in 0.05 M sodium 108 
phosphate buffer pH 7.4), and containing 250 I.U./g of heparin (Leo Laboratories, Princes 109 
Risborough, Bucks), was also infused at a rate of 40 g/h into the mesenteric vein over the 110 
period 15-20 h. This was mixed with the appropriate AA or 0.15 M sodium chloride infusate 111 
via a t-piece connector.  From 12 to 20 h, a solution of 15 mM [
2
H5]phenylalanine (99 atom 112 
%; Cambridge Isotope Laboratories, Andover, MA, USA) in 0.15 M sterile saline was infused 113 
at 10 g/h into the jugular vein, again via a t-piece connector.   114 
 Between 16 to 20 h of LPS-infusion, blood was withdrawn continuously over iced-115 
water as 4 x 1h samples from the arterial, portal and hepatic venous catheters
(18)
 with 12 ml 116 
taken for each collection. At 12 and 20 h, 20 ml of arterial blood was withdrawn and  117 
maintained at room temperature for immediate processing of lymphocytes. At 20 h, the 118 
various infusions were stopped and 6 g of a sterile saline containing 24 mg of Evan’s Blue 119 
Page 5 of 43
Cambridge University Press
British Journal of Nutrition
For Review Only
6 
 
injected via the jugular catheter. Then 2.5 ml of blood were withdrawn at 3, 6, 9 and 12 min 120 
after injection to allow estimation of plasma volume
(19)
.  121 
 122 
Chemical analyses 123 
Clinical blood parameters were determined as described previously
(3)
. Immediately following 124 
each hourly collection, blood analysis (pH, pO2, pCO2 and haemoglobin) was performed with 125 
an ABL650 Blood Gas Analyser (Radiometer, Copenhagen, Denmark) and packed cell volume 126 
determined by micro-centrifuge. Blood samples were then centrifuged at 1000 g for 15 min 127 
and the plasma used for various analyses using gravimetric procedures
(18)
. All blood samples 128 
taken were analysed individually, parameters were then calculated separately for each hour 129 
of collection and then the mean of these used for statistical analysis.  130 
The p-aminohippurate concentration was quantified on 0.7g plasma
(18)
 while 1g plasma 131 
from each sample site was retained for enrichment analysis of [
2
H5]phenylalanine. To 132 
another 1.4 g plasma was added 0.6 g of a mixture of [U-
13
C] algal hydrolysate containing [5-133 
15
N]glutamine, [indole-
15
N]tryptophan, [1-
13
C]cysteine and [
15
N2]urea to allow determination 134 
of AA concentrations by isotope dilution
(20,21)
. This sample was divided into two equal 135 
portions with one kept in reserve. A further portion of fresh plasma (0.4 g) was analysed 136 
with commercial kits for total protein, albumin, glucose (Thermo Scientific; kits 981-387, 137 
981-767, 981-304, respectively), ammonia (Sentinel Diagnostic; kit 17660) and  lactate 138 
(Trinity Biochemicals;  kit 735-10) on a clinical analyser (Kone Limited). Plasma albumin was 139 
isolated from arterial plasma
(22)
. Concentrations of Evans Blue bound to plasma protein were 140 
determined spectrophotometrically
(19)
 and values extrapolated to zero time injection to 141 
allow estimation of plasma volume. Determination of the enrichments of plasma free 142 
[
2
H5]phenylalanine  and the extraction, hydrolysis and analysis of both albumin and plasma 143 
total protein labelled with [
2
H5]phenylalanine were as described previously
(22)
. Lymphocytes 144 
were isolated from the 20 ml blood samples taken at the start and end of the isotope 145 
infusion. The blood was first gently diluted 1:1 with 0.15 M NaCl and 5 ml portions slowly 146 
layered onto 5 ml Histopaque 1077 lymphocyte separation media (Sigma Bioscience), in 8 147 
separate tubes, with care taken to avoid mixing of the two layers. The tubes were then 148 
centrifuged at 700 g for 20 minutes at 20
o
C with no brake applied. The lymphocyte layer at 149 
the interface was then carefully removed by Pasteur pipette from each tube and these all 150 
transferred to a 10 ml glass hydrolysis tube and diluted to 10 ml with ice-cold 0.15 M NaCl 151 
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saline. This solution was centrifuged at 1500 g for 15 min at 4
o 
C and the pellet re-suspended 152 
in 4 ml of ice-cold lysis buffer (9:1 (vol:vol) ammonium chloride (8.3 g/l ): 0.17 M Tris-HCl 153 
buffer pH 7.65). This was re-centrifuged at1500 g for 15 min at 4
o
C
 
 and the supernatant 154 
containing the contents from red blood cell lysis decanted. The pellet was then washed with 155 
ice-cold saline and re-centrifuged on three more occasions. After the final wash the pellet 156 
was re-suspended in 5 ml of distilled water and stored frozen at –20
o
C until further analysis. 157 
Lymphocyte protein was prepared in a manner similar to the general procedure for albumin 158 
and total plasma protein and involved thawing the stored suspension and deproteinisation 159 
with addition of 0.8 ml of 48 % (w/v) sulphosalicylic acid (SSA). After standing on ice for 10 160 
min the sample was centrifuged at 1500 g for 20 minutes at 4
 o
C. The sample was then 161 
washed twice with 8 ml 8 % ice cold SSA and centrifuged on each occasion. The supernatant 162 
was removed and to the pellet a phenol crystal was added (to protect aromatic AA against 163 
oxidation) followed by 4 ml of 4 M HCl.  This was then hydrolysed for 18 h at 105
o
C in a 164 
heating block. Subsequent steps were then as described previously
(22)
.  165 
 166 
 167 
Calculations 168 
 Plasma flows (kg/min) were determined by a gravimetric approach
(18)
 with 169 
blood flow calculated from plasma flow/(1-packed cell volume). Hepatic artery (A) 170 
flow (blood or plasma) was determined as the difference between the flows in the 171 
hepatic vein (FH) and hepatic portal vein (FP). The plasma and blood water flows 172 
were calculated from the dry matters in order to quantify urea transfers
(23)
. In general, 173 
net mass transfers (µmol/min) of individual AA or metabolites across the PDV were 174 
calculated as: 175 
 (Ch × FH) – (Cp ×  FP) – (Ca ×  FA) 176 
where Ca, Cp and Ch are metabolite concentrations (µmol/kg) in arterial, hepatic portal vein 177 
and hepatic vein fluids (blood for oxygen, ammonia; blood water for urea; plasma for all 178 
other measurements).  179 
 For protein synthesis (µmol/min) estimates based on isotope transfers across 180 
the gastro-intestinal tract and liver the appropriate calculations were:   181 
across the portal drained viscera (PDV)  182 
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(Cp ×  Ep -Ca ×  Ea) ×  FP/ Ex 183 
and across the liver:  184 
 ×  ×  − 
 ×  ×  −  ×  × 

 
where Eh, Ep and Ea,  are the respective enrichments (molar % excess) of free 185 
[
2
H5]phenylalanine in plasma from the hepatic vein, portal vein and artery, and where Ex is 186 
the enrichment value selected as representative of  the precursor pool. For comparison with 187 
whole body irreversible loss rate measurements then Ex was based on the arterial value, but 188 
for other comparisons Ex was assumed similar to hepatic venous enrichments as this has 189 
been shown to reflect well values for export proteins
(22)
. Both estimates of precursors, 190 
however, are less than values observed in the intracellular pools of either the liver
(22)
 or the 191 
gastro-intestinal tract
(24)
. For both net transfer data and isotope kinetics the concentrations, 192 
enrichments and flows were calculated for each individual hour of collection and then 193 
averaged. 194 
 Whole body irreversible loss rate (WB ILR, mmol/h) of tracee were estimated by the 195 
standard procedure i.e. 196 
 = (99/Ea – 1) × infusion rate (mmol/h) 197 
where 99 is the enrichment (molar % excess) of the [
2
H5]phenylalanine infusate.  198 
 Enrichments for both total protein and albumin from plasma altered in a linear 199 
manner over the times of collection and their respective gradients (change molar % 200 
excess/h) were divided by Eh (representative of the precursor for export proteins
(22)
) and 201 
adjusted to give daily fractional synthesis rates (FSR). These FSR were then converted to 202 
absolute synthesis rates (g/d) by: 203 
 = FSR/100 × plasma concentration (g/l) × plasma volume (l) 204 
Where total plasma volume was determined by dilution of Evans Blue
(19)
. For lymphocytes, a 205 
value of 28.2 pg protein/cell was adopted
(25)
. 206 
 207 
Power calculations and statistical analyses 208 
 209 
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 The number of sheep per treatment group (control combined with LPS or control 210 
combined with LPS+AA) was based on comparing the effect of LPS+AA to the effect of LPS 211 
alone. The power calculations were performed at a power of 80% for the 5% significance 212 
level, with the between-sheep variance obtained from previous studies
(3,22)
. A considerable 213 
number of parameters were to be assessed in this study but the decision on number of 214 
sheep per treatment group was based on the following two outcomes that were deemed 215 
most  indicative of the restorative effect of AA supplementation on an LPS challenge.  The 216 
first parameter  involved restoration of  the arterial concentrations for the 6 AA infused in 217 
combination with LPS to at least 90% of the control (saline) values. Expected decreases for 218 
these six AA were expected to be 23 to 73% by the action of LPS alone
(3)
 with between-sheep 219 
SD 13-43% of control values
(3)
, yielding n per group=4. The second parameter involved 220 
changes fractional synthesis rate for plasma albumin, a negative acute phase protein, and 221 
based on an SD of 0.49 %/d
(22)
, a change of 1.4%/d, equivalent to the difference between fed 222 
and fasted sheep
(22)
, would be observed with n per group=4.   Additional power was gained 223 
by initial selection of  6 sheep per treatment group. Unfortunately, one sheep required to be 224 
euthanised during the surgical procedure, while three others developed either non-patent 225 
catheters in either the portal or hepatic veins before the end of the study. Thus 11 sheep 226 
had measurements reliant on arterial samples (this included the two criteria  used for the 227 
power calculations above) but only 4 sheep per treatment group for the full splanchnic 228 
transfers. In practice the changes based on arterial values only were similar between the 11 229 
and 8 sheep comparisons. Therefore, for the main text, data are presented for the 8 sheep 230 
that had the full working splanchnic-bed catheters. Of these, four received a saline infusion 231 
or LPS infusion on two separate days. The other four sheep received a saline infusion or 232 
LPS+AA infusion on two separate days. The order of infusions was randomised within each 233 
group. Although this is small study, the use of a frequent feeding regimen, continuous 234 
administration of low dose of LPS over the experimental duration and collection of 235 
integrated blood samples all helped reduce associated variance and meant that fewer 236 
animals were needed to detect statistical differences. In addition, where appropriate, results 237 
from the 11 sheep are presented as online Supplementary material. 238 
 239 
 Data were analysed as a mixed model using the residual maximum likelihood (REML) 240 
estimation procedure in Genstat 13
th
 edition, release 13.2 (VSN International, Hemel 241 
Hempstead, UK). The influence of LPS (independent of whether AA were infused or not) was 242 
assessed with sheep and period (experimental day) within sheep as random effects while 243 
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period and LPS status (present or absent) and their interaction were regarded as fixed 244 
effects. To assess the influence of AA infusion, sheep and period within sheep were 245 
considered as random effects while period and treatment and their interaction were 246 
considered as fixed effects, where treatment involved saline, LPS and LPS + AA infusions.  247 
All data are presented as predicted means from the REML analysis, with the maximum SED 248 
value also given for the various comparisons. P<0.05 was taken as evidence of a significant 249 
response and 0.05<P<0.10 as weak evidence 250 
   251 
Results 252 
Whole body responses and arterial concentration changes 253 
Within the first 4 h of LPS infusion there were increases in body temperature (1.0-2.0°C) and 254 
respiration rate, as observed previously
(3)
. During the same period, occasionally there were 255 
mild reluctances to eat but this never exceeded more than two hourly meals, and these was 256 
eaten soon thereafter so for the total 20 h there were no refusals. Over the period of blood 257 
collection (16-20 h after the start of LPS or vehicle infusion), endotoxaemia did not affect 258 
either arterial blood pH or haemoglobin status (data not shown). Haemoglobin was lower 259 
during the second period (10.7 v. 9.1 SED 0.61, P = 0.027), as was plasma albumin (27.1 v 260 
26.5 g/l, SED 0.22, P = 0.013), both possibly related to the amount of blood withdrawn over 261 
the various procedures. Blood white cell numbers were slightly increased just prior to LPS 262 
infusion for the second period (10.24 v. 12.25 x 10
9
 cells/l blood, SED 0.870, P = 0.046). Most 263 
of this could be attributed to whether the sheep had received LPS or saline during the first 264 
period (respectively 14.63 v. 11.35 x 10
9
 cells/l blood, SED 1.487, P = 0.055). There were no 265 
differences between allocated groups (saline or LPS) in white cell count prior to period 1. 266 
There were no period or previous treatment effects on the proportion of neutrophils (34%) 267 
and lymphocytes (64%) in the monocyte population prior to each infusion period. At the end 268 
of the 20 h infusion, numbers of lymphocyte cells had more than doubled in response to LPS 269 
challenge compared with saline infusion (Table 1).  270 
Endotoxaemia tended to cause a 30% decrease in arterial glucose (P = 0.067), while 271 
lactate concentrations were unaffected (Table 1). Arterial plasma concentrations of both 272 
total protein (-6%, P = 0.018) and albumin (-4%, P = 0.007; Table 1) were reduced by LPS. In 273 
contrast, while the FSR of albumin was also decreased (-48%, P < 0.001) that of total protein 274 
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was increased (+37%, P 0.012; Table 2). As total plasma volume (average 2.18 l) was 275 
unaffected by either period or treatment, then similar directions of change were also 276 
observed for the ASR of both albumin and total protein (both P < 0.01; Table 2) in response 277 
to LPS.  The substantial increase in lymphocyte numbers was accompanied by a 63% increase 278 
in FSR (P = 0.043 Table 2), while the ASR was elevated by 386% (P< 0.001). For all these 279 
variables, the responses to LPS were independent of whether the supplemental AA were 280 
provided or not. Responses reported in both Table 1 and 2 for the 8 sheep with complete 281 
functional catheters across splanchnic  tissues at the end of the study were similar to data 282 
obtained from the original 11 sheep (online Supplementary Tables S1 and S2).   283 
  284 
Arterial plasma concentrations of AA 285 
For most non-infused AA, the arterial plasma concentrations were reduced 286 
substantially with both LPS and LPS+AA treatments (by 20-50%, P < 0.01; Table 3). The 287 
exceptions were tryptophan, wher  only a tendency was observed (-15%, P = 0.079), while 288 
for phenylalanine the plasma concentration increased (+30%, P < 0.001). The reductions for 289 
the non-infused AA were not influenced by the infusion of the six AA. LPS infusion also 290 
increased plasma urea (22%, P =0.014).  291 
For the 6 AA that formed the supplement, these also showed decreased plasma 292 
concentrations when the sheep were challenged with LPS but infused with saline 293 
(reduced by 14-74%, all P < 0.05). For the four sheep where the supplement was 294 
infused this restored plasma concentrations to saline-infused values for cysteine, 295 
glutamine, methionine, proline and serine (Table 3). The infusion of threonine over-296 
compensated (P=0.007). 297 
 298 
Splanchnic bed metabolism 299 
Plasma flows in the portal vein, hepatic vein and hepatic artery (means 1.347, 1.428 300 
and 0.080 kg/min respectively) were not altered by the endotoxin challenge (data not 301 
shown). Neither were there any effects of LPS (with or without supplemental AA) on 302 
splanchnic tissue oxygen uptake (-112 and –113 µmol/min for PDV and liver, respectively). 303 
Although glucose concentrations were higher in the hepatic vein than either the portal vein 304 
or hepatic artery (3.81, 3.56, 3.51 mM, respectively, SED 0.041, P<0.001) with, in 305 
consequence, more glucose appearance across the liver than the PDV (+360 vs + 89 306 
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µmol/min, SED 79.1, P<0.001), there was no effect of LPS infusion, with or without infused 307 
AA present. Similarly, lactate transfers were also unaffected by endotoxaemia (-130 and +64 308 
µmol/min for PDV and liver, respectively).  309 
 310 
PDV AA transfers 311 
All AA, except glutamine, showed net positive appearances (uptake) across the PDV 312 
under the various experimental conditions (Table 4). Over the 4 h of sampling, infusion of 313 
LPS did not alter net PDV appearance, compatible with the lack of effect of the endotoxin on 314 
food intake. In contrast, the net PDV appearance of glutamine across the PDV was negative 315 
during saline infusions (indicative of metabolism of endogenous glutamine by the gut 316 
tissues) but this was reduced by 67% (P=0.014) with LPS infusion (without supplemental AA). 317 
Neither removal of urea nor appearance of ammonia across the PDV was affected by LPS 318 
infusion. As expected, mesenteric vein infusion of the six AA increased their portal vein 319 
appearance (all P < 0.001). For the 6 infused AA, apparent recovery within sheep across the 320 
PDV were not significantly different from 100% for methionine, proline, serine, threonine 321 
and glutamine, but only  71% for cysteine (P=0.004). The amount of glutamine infused was 322 
sufficient to provide a net positive supply to the liver (Table 4). PDV appearances of alanine 323 
and lysine (both P < 0.05) were also increased by infusion of the AA supplement. For alanine 324 
this restored values to those of the saline-infused period, while for arginine net supply 325 
increased above that for the control (saline) period (P =0.012).   326 
 327 
Hepatic AA transfers 328 
 Except for glutamine and glutamate, during saline infusion there was net removal of 329 
each AA across the liver and these were different from zero (P<0.05) except for aspartate 330 
and cysteine. During saline infusion, there was net hepatic export of glutamate (P<0.001). 331 
LPS infusion (without supplemental AA) increased net hepatic removal (P<0.05) of 6 AA 332 
(Table 5) and these contributed to the 75% extra extraction of total AA-N (P = 0.012). For the 333 
non-infused AA, hepatic removal was not affected by the supplemental AA in the presence 334 
of LPS (Table 5). In contrast, extraction by the liver of all the infused AA was markedly 335 
increased (P<0.01) and this resulted in an additional 40% removal of total AA-N  (P=0.030).  336 
 337 
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Net splanchnic AA transfers 338 
The difference between net absorption (plus any infused AA) and hepatic removal 339 
represents net splanchnic flow to peripheral tissues (Table 6). With saline infusion, only 340 
glycine and glutamine had significant (P<0.05) negative net transfers i.e. hepatic uptake 341 
exceeded PDV absorption and thus additional amounts were removed from the peripheral 342 
circulation. In terms of positive net post-splanchnic supply, most AA had values that were 343 
significantly different from zero (P<0.05), the exceptions were alanine, cysteine, histidine, 344 
phenylalanine, tryptophan and tyrosine. In response to LPS alone, net splanchnic supply 345 
decreased for alanine and arginine (P < 0.05). Provision of supplemental AA increased net 346 
splanchnic supply for cysteine, methionine, proline, threonine (all P<0.010) and serine 347 
(P=0.037), but not glutamine.  348 
 349 
Isotope transfers 350 
Phenylalanine whole body ILR was increased in response to LPS infusion, both with 351 
and without the AA supplement (mean 17%, P < 0.001; Table 7). Endotoxaemia did not alter 352 
ILR across the PDV, regardless of whether the arterial or venous plasma enrichment was 353 
chosen as precursor (latter data not shown). In contrast, with either method of calculation, 354 
both liver (P = 0.023) and total splanchnic (P = 0.034) metabolism was increased by LPS. In 355 
combination, LPS plus supplemental AA increased hepatic protein synthesis by 12% 356 
(P=0.036) compared with LPS alone. Together, the hepatic and PDV response accounted for 357 
approximately 40% of whole body ILR under both saline and LPS infusions, but with the 358 
contribution from the liver more than 2-fold that from the PDV.  359 
 360 
DISCUSSION 361 
Although experimentally-induced endotoxaemia has proved a popular research tool to study 362 
the metabolic events and beneficial nutrition interventions related to inflammation, the 363 
responses observed can vary due to many factors, including species, severity of dose and 364 
period of measurement. For example, in both pigs
(4)
 and sheep
(3)
 LPS causes a decrease in 365 
plasma concentration for most AA. In contrast, in rodents concentrations can increase
(26)
, 366 
while in humans both null
(27)
 or decreased
(28)
 responses have been reported.  The dose 367 
employed in the current study is below that usually adopted, for example only 4% of the 368 
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hourly dose used in pigs
(4)
 but does give the advantage that pyrexia and anorexia responses 369 
are mild and of limited duration yet with similar responses in arterial AA concentrations and 370 
metabolic flows
(3)
.  371 
 372 
Whole body and splanchnic tissue response to endotoxin challenge 373 
The LPS dose increased whole body ILR of plasma phenylalanine in the sheep, as observed 374 
previously
(3)
, in support of observations in pigs
(1)
 and humans
(27)
.  Similarly, the increase in 375 
lymphocyte cell numbers is in agreement with other findings during infection and 376 
inflammation challenges
(3,29)
, although in shorter-term endotoxaemia studies (< 2.5 h) in 377 
human such changes are not observed
(30)
. Increased cell numbers may involve mobilisation 378 
of lymphocytes from pre-existing stores and/or a higher fractional rate of synthesis and the 379 
current data confirm that the latter occurred. Nonetheless, the 4-fold increase in total 380 
protein synthesis of lymphocytes represented < 0.1% of whole body protein synthesis and 381 
would only require <0.2% of the phenylalanine absorbed from the diet. In contrast, the net 382 
increase in total plasma protein synthesis (4 g/d, from Table 2) would require an additional 383 
5% of the absorbed phenylalanine.  The latter value compares with estimates for the total 384 
immune system of approximately 8% in humans
(31)
 and with nutritional costs increased from 385 
1.2 to 6.7% between saline-infused and LPS-challenged chicks
(32)
. Other components of the 386 
immune system, not monitored in the current study and including the thymus, spleen, bone 387 
marrow and immune cells, may also be activated
(33)
 with a possible greater contribution 388 
from secondary lymphoid organs compared with primary tissues plus blood lymphocytes
(29)
.  389 
 Although endotoxaemia is associated with changes in NO status
(26)
, blood (and 390 
plasma) flows across the splanchnic tissues remained unaltered.  Again this is in line with 391 
observations in both pigs
(4,26)
 and rodents
(26)
. In humans, a near doubling of splanchnic blood 392 
flow was observed
(27)
 but this had disappeared 6 h after the bolus injection of endotoxin. LPS 393 
also exerts direct effects on the gut, with consequent damage
(34)
 and altered permeability
(15)
. 394 
It is clear, however, that there was no impact on net absorption  of most AA in the current 395 
experiment but this may relate to the parenteral route of LPS infusion and the low dose 396 
employed. Therefore, the altered arterial AA concentrations   must be a consequence of 397 
altered post-intestinal tract metabolism. This contrasts with the pig where, following a more 398 
severe endotoxin challenge supplied enterally,  increases in net portal vein appearance for 399 
several AA were approximately double that supplied from the diet, suggestive of 400 
mobilisation of intestinal tissue
(4)
. 401 
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 In the current study, glutamine showed lowered net removal in response to LPS.  402 
This has similarities to observations in both pigs post-surgery
(35)
 and tumour-bearing rats
(17)
 403 
where the gut consumed less glutamine, possibly in response to lowered arterial 404 
concentrations. Indeed, arterial glutamine, and thus systemic supply, was reduced by 38% in 405 
the current study 406 
 Under control conditions, hepatic AA removal followed patterns previously 407 
reported
(36,37)
, with most of the net absorbed histidine and phenylalanine extracted, but with 408 
only limited uptake of the branch-chain AA (17-27%). There was net output of glutamate 409 
but, contrary to earlier observations, this was not balanced by similar net hepatic glutamine 410 
removal
(23,38)
. More N was extracted from plasma by the liver as combined AA-N and 411 
ammonia-N than was released as urea-N, compatible with hepatic needs to support other 412 
processes
(23)
, including synthesis of constitutive and export proteins. Part of the difference 413 
(4.5 mmol/h) would be used to support the measured albumin synthesis (1.4 mmol-N/h), 414 
but would be insufficient to account for estimated total plasma protein synthesis (7.2 mmol-415 
N/h), although not all plasma proteins are synthesised by the liver (e.g. globulins).   416 
LPS infusion increased hepatic removal for several AA, including glutamine, leucine, 417 
lysine, proline and threonine, and these contributed to the additional 6.5 mmol AA-N/h net 418 
removal by the liver, similar to the 8.3 mmol-N/h estimated from the change in total liver ILR 419 
(from Table 7).  How much of this additional uptake of AA-N is catabolised is unclear because 420 
the numerical change in arterial urea was not supported by increased hepatic ureagenesis. 421 
Studies in humans have reported increased AA catabolism due to LPS, including hepatic 422 
oxidation of leucine
(27)
, greater fractional extraction of leucine across the splanchnic bed 423 
during sepsis
(39)
 and elevated whole body conversion of phenylalanine to tyrosine
(40)
, 424 
primarily a liver event. In addition,  infection or inflammation stimulate synthesis of 425 
constitutive and/or export proteins
(1,4,33,41)
.  426 
Phenylalanine is unusual in that the arterial concentration increases during 427 
endotoxaemia in pigs
(4)
 and sheep
(3)
, although not humans
(27,28)
.  Hepatic removal of 428 
phenylalanine remained unchanged by LPS treatment even though it has been suggested 429 
that liver demands for phenylalanine (and tryptophan) would increase during infection and 430 
inflammation due to their relatively high abundance  in positive acute phase proteins
(7)
, the 431 
synthesis of which is increased by infection
(42)
. In the current study, such demands would be 432 
offset by simultaneous decreased synthesis (-50%) of albumin, a negative acute phase 433 
protein that contains 6% (w/w) phenylalanine.  Therefore, the increased arterial plasma 434 
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phenylalanine probably relates to mobilisation of protein from non-splanchnic tissues, 435 
particularly skeletal muscle
(1,43)
.   436 
 437 
Effect of AA supplementation 438 
 Targeted supply of nutrients in response to specific physiological, developmental or 439 
environmental events is a key nutritional aim. In various clinical situations much attention 440 
has been focused on demands for specific AA. For example, supplementation with large 441 
amounts of glutamine has been proposed for a variety of surgical and clinical states
(16,44-46)
 442 
associated with specific needs for the immune system
(47)
. In addition, claims as effective 443 
therapies have been made for a number of other AA supplied alone
(48-50)
. Other benefits 444 
have involved AA in combination
(13,14)
, although these have not always been successful
(51)
.  445 
A recent approach involved dynamic measurements in sheep subjected to an LPS 446 
challenge in order to quantify the demands for specific AA
(3)
, and these findings were applied 447 
within the current protocol.  The success of such an approach can be assessed at several 448 
levels. The simplest involves the effect of supplementation on plasma AA concentrations and 449 
this produced statistical restoration to the saline-infused values for 5 of the AA, although 450 
further numerical improvement would be preferred for cysteine and serine. In contrast, 451 
threonine was probably over-supplied based on previous sheep data
(3)
and there may be 452 
differences between studies in the sensitivity of the animals to the LPS dose. Notably, earlier 453 
LPS caused an 80% reduction in plasma threonine
(3)
, while for the current animals the 454 
decrease was only 56% and so less than actually given might have been needed to restore to 455 
control values. Recovery of AA infused into the post-absorptive venous drainage was not 456 
different from unity, except in the case of cysteine, possibly due to the requirement for 457 
synthesis of taurine and glutathione, processes that occur within the intestinal cells
(52,53)
.  458 
Based on the hypothesis that AA are mobilised from tissue protein, particularly 459 
muscle
(43,54)
, to combat inflammation and if one (or more) of these AA are needed in 460 
considerable amounts then this will leave the remainder that are released in excess to 461 
requirements for protein synthesis. These will then be removed from the body via 462 
ureagenesis and lead to depletion of plasma concentrations. If the supplement contains 463 
those AA needed to support the anti-inflammatory responses, then this should reduce the 464 
need for peripheral tissue mobilisation and lower the overall hepatic removal for catabolic 465 
purposes.  Despite the reasonable success in restoring the plasma concentrations of the 466 
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supplemented AA to normal, there was no improvement in the plasma concentrations of the 467 
non-supplemented AA and neither was there a reduction in their removal by the liver 468 
between the LPS and LPS+AA treatments. For the supplemented AA, only for glutamine was 469 
there complete removal of the extra provided. This suggests that the increased arterial 470 
glutamine concentrations are probably due to mobilisation from other tissues; muscle is an 471 
obvious candidate where milli-molar quantities of free glutamine are present
(55)
 and which is 472 
released during severe illness, even in the presence of supplemental glutamine
(56)
. For the 473 
other supplemented AA, hepatic removal ranged from 55% (proline) to 84% (serine) so the 474 
fates were partitioned between increased post-hepatic delivery, necessary to restore arterial 475 
concentrations to, or above, normal and potential support of liver-based mechanisms. The 476 
latter did not, however, involve restoration of the synthesis of the negative acute phase 477 
protein, albumin. This non-response was despite the fact that the increased hepatic uptake 478 
of the supplemented AA would, in theory, have the potential to support 30-130 g/d of 479 
albumin synthesis, in considerable excess of the 1g/d decrease observed. Similarly, the 480 
additional AA supplement did not alter rates of synthesis of lymphocytes. These 481 
observations might suggest that either other AA are needed in the supplement or that the 482 
immediate events during inflammation are less responsive to supplementation, e.g. there is 483 
a metabolic ’over-ride’, and perhaps the focus should be on longer–term responses and 484 
enhanced recovery, as has been shown to occur in rats treated with exotoxin and 485 
supplemented with AA
(14)
.   486 
In summary, infusion of 6 AA predicted as key requirements during the response to 487 
an LPS challenge restored or exceed arterial concentrations of these to control values but 488 
not any of the other non-infused AA. Similarly, there was no restoration of the synthesis of 489 
the negative acute-phase protein, albumin, and no change in the elevated protein synthesis 490 
of lymphocytes. The parenteral infusion of the low dose of LPS did not affect gut metabolism 491 
or net AA absorption except for glutamine, where net removal was reduced. Hepatic uptake 492 
of leucine, lysine, glutamine and serine was increased by LPS, with liver removal of the latter 493 
two plus the other 4 infused AA increased during the AA supplementation.  The data suggest 494 
that AA supplementation does not mitigate certain  metabolic demands during the acute 495 
phase of an endotoxin challenge but whether supplementation provides benefits on later 496 
responses and the period of recovery requires further investigation. 497 
 498 
 499 
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Table 1. Impact of a 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), on 
arterial concentrations of albumin, total protein, glucose, lactate and lymphocytes in 8 sheep. 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment  P 
 Saline LPS LPS+AA SED Treatment
*
 Period
*
 LPS status
†
 
Albumin (g/l) 27.3
a 
26.7
ab
 25.8
b
 0.48 0.021 0.022 0.007 
Protein (g/l) 62.2 59.9 58.1 1.85 0.059 NS 0.018 
Glucose (mM) 4.09
 
 2.59 3.25 0.567 0.070 NS 0.067 
Lactate (mM) 1.42 1.19 1.56 0.566 NS NS NS 
Lymphocytes
 
(10
9
 
cells/l)
 ‡
 
4.58
a
 11.04
b
 10.74
b
 1.182 0.002 NS <0.001 
 
LPS lipopolysaccharide, AA amino acids infused 
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* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. There were no period x treatment effects (P>0.05). Where there was a treatment effect 
(P<0.05), post-hoc t-test was performed to compare the treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡
 One missing value (for LPS treatment)
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Table 2. Effect of 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), on 
synthesis rates of plasma albumin, total plasma protein and lymphocytes in 8 sheep  
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment  P 
 Saline
 
LPS
 
LPS+AA SED Treatment
* 
Period
* 
LPS status
†
 
Albumin 
  FSR (%/d) 
  ASR (g/d) 
 
4.88
a 
2.92
a
 
 
2.22
b
 
1.35
b
 
 
2.52
b
 
1.38
b
 
 
0.462 
0.430 
 
<0.001 
0.004 
 
NS 
NS 
 
<0.001 
0.001 
Total protein 
  FSR (%/d) 
  ASR (g/d)
 ‡  
 
11.4
a
 
15.2
a
 
 
16.2
b
 
19.2
ab
 
 
15.1
b
 
21.2
b
 
 
1.49 
1.83 
 
0.043 
0.048 
 
NS 
NS 
 
0.012 
0.007 
Lymphocytes 
FSR (%/d) 
ASR (mg/d)
**
  
 
6.33
a
 
25.0
a
 
 
10.95
b
 
91.2
b
 
 
9.68
ab
 
101.5
b
 
 
1.75 
19.85 
 
0.025 
<0.001 
 
0.032
§
 
0.034
§
 
 
0.043
§
 
<0.001 
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LPS lipopolysaccharide, AA amino acids infused, FSR fractional synthesis rate, ASR absolute synthesis rate 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. Where there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the 
treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
†
 Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡
 Period x treatment effect (P=0.029) values lower during period 2 for LPS treatment (similar between periods for saline and LPS+AA infusions). 
 
§
 Values lower during period 2. 
 
**
 One missing value (LPS)
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Table 3.  Effect of a 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), on 
plasma arterial concentrations (µmol/kg) of amino acids in 8 sheep.  
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment  P 
 Saline LPS LPS+AA SED Treatment
*
 Period
*
 LPS
†
 
Non-infused AA  
Alanine 162
a
 105
b
 98
b
 12.7 0.001 NS <0.001 
Arginine 164
a 
79
b 
106
b 
20.6 0.005 0.085
‡
 <0.001 
Aspartate 8
a
 4
b 
5
b 
1.27 0.015 NS 0.009 
Glutamate 83
a 
53
b 
58
b 
9.5 0.015 NS 0.005 
Glycine 477
a 
255
b
 217
b 
36.5 <0.001 NS <0.001 
Histidine 60
a 
44
b 
50
ab 
5.1 0.026 NS 0.009 
Isoleucine 74
a 
49
b
 42
b 
7.2 <0.001 NS <0.001 
Leucine 78
a 
69
ab 
54
b 
7.1 0.015 NS 0.025 
Page 28 of 43
Cambridge University Press
British Journal of Nutrition
For Review Only
29 
 
Lysine 124
a 
66
b 
55
b 
14.7 0.001 0.042
‡ 
<0.001 
Phenylalanine 45
a
 60
b 
58
b 
2.2 <0.001 NS
§
 <0.001 
Tryptophan 31
a 
25
b 
28
ab 
2.2 0.100 NS 0.079 
Tyrosine 59
a 
44
b 
45
ab 
7.2 0.041 NS 0.007 
Valine 163
a 
132
b 
110
b 
14.2 0.006 NS 0.002 
Urea 4199
a 
5105
a 
5151
a 
583.0 0.086 NS 0.014 
 
Infused AA 
 
Cysteine 86
a 
60
b 
82
ab 
9.1 0.035 NS 0.083 
Glutamine 333
a 
207
b 
301
a 
20.6 <0.001 0.041
‡¶
 0.038 
Methionine 22
a 
7
b 
28
a 
5.0 0.015 0.034
‡
 NS 
Proline 73
a 
40
b 
77
a 
11.8 0.030 NS NS 
Serine 56
a 
23
b 
44
a 
7.4 0.008 NS 0.037 
Threonine 86
a
 38
a 
144
b 
24.0 0.007 NS
¶
 NS 
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LPS lipopolysaccharide, AA amino acids infused 
 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. Where there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the 
treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡ 
Values greater in Period 2.  
 
§
 Period x Treatment effect (P=0.009), with lower values for LPS+AA during Period 2. 
 
¶
 Period x Treatment effect (P=0.003 for glutamine,; P=0.04 for threonine), with greater values for LPS+AA during Period 2. 
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Table 4. Net PDV supply (absorbed from diet + any infused AA) of amino acid-N (µmol N/min) in 8 sheep in response to 20 h infusions of saline or 
lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA). 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
  
  treatment  P  
 Saline LPS LPS+AA SED
+ 
Treatment
*
 Period
*
 LPS
†
 
Non-infused AA-N  
Alanine 31.3
ab 
24.0
 
39.9
c 
3.06 0.015 NS NS 
Arginine 34.2
a 
19.6
b 
60.2
c 
4.32 0.006 0.017
‡
 NS 
Aspartate 4.3 3.4 3.5 1.50 NS
¶
 NS NS 
Glutamate 5.1 14.8 13.0 5.03 NS NS 0.083 
Glycine 20.0 18.1 25.2 2.68 NS NS NS 
Histidine 18.6 15.0 19.0 2.58 NS NS NS 
Isoleucine 15.5 12.3 17.3 2.28 NS 0.053
‡
 NS 
Leucine 19.1 15.0 22.9 2.60 0.079 NS NS 
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Lysine
§
 40.6
a
 30.3
b
 51.3
c
 4.43 0.021 0.034
‡
 NS 
Phenylalanine 12.3 9.7 13.8 1.36 0.075 0.062
‡
 NS 
Tryptophan 3.7 2.5 6.0 1.57 NS 0.093
‡
 NS 
Tyrosine 10.5 7.9 12.2 1.41 0.084 0.069
‡
 NS 
Valine 17.4 13.4 19.3 2.58 NS NS NS 
Urea-N -259 -359 -329 101.5 NS NS NS 
Ammonia 547
 
433
 
807
 
139.3 0.083 NS NS 
 
Infused AA-N
§ 
 
Cysteine 1.9
a 
1.8
a 
15.5
b 
0.79 <0.001 NS 0.052 
Glutamine -51.6
a 
-17.6
b 
27.4
c 
11.59 <0.001 NS 0.002 
Methionine 6.4
a 
6.2
a 
17.7
b 
1.09 <0.001 NS 0.071 
Proline 10.9
a 
10.2
a 
26.0
b 
1.95 <0.001 NS NS 
Serine 24.1
a 
21.0
a 
55.0
b 
4.62 <0.001 NS NS 
Threonine 13.8
a 
12.2
a 
46.7
b 
2.73 <0.001 NS 0.099 
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PDV portal-drained viscera, LPS lipopolysaccharide, AA amino acids infused 
 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. There were no period x treatment effects (P>0.05). Where there was a treatment effect 
(P<0.05), post-hoc t-test was performed to compare the treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡ 
Values lower for Period 1 than Period 2 except for arginine where Period 1 was greater. 
 
§
 infusion rates (µmol-N/min) into mesenteric vein, 17.8 (proline), 10.8 (methionine), 34.7 (serine), 38.4 (threonine), 19.2 (cysteine), 89.2 (glutamine) for 
LPS+AA treatment. 
 
¶ 
Only 3 sheep for the LPS+AA treatment
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Table 5. Net hepatic removals (µmol N/min) of amino acid-N in 8 sheep in response to 20 h infusions of saline or lipopolysaccharide (LPS; 2 ng/kg LW per 
min), either with or without six supplemental amino acids (AA). 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
  treatment  P  
 Saline LPS LPS + AA SED
+
 Treatment
*
 Period
*
 LPS
†
 
Non-infused AA-N  
Alanine -24.8
a 
-35.6
b 
-36.7
b 
5.05 0.028
 
0.052 0.004 
Arginine -25.9
a 
-42.9
ab 
-60.6
b 
9.51 0.032
‡
 NS 0.031 
Aspartate -0.6 -2.0 -1.2 1.08 NS NS
§
 NS 
Glutamate 16.8 6.4 -4.7 6.70 NS NS NS 
Glycine -30.5 -38.1 -35.8 5.18 NS NS NS 
Histidine -18.9 -21.8 -20.8 2.06 NS
 
0.020
||
 0.058 
Isoleucine -2.6
 
-4.9
 
-5.3
 
0.96 0.074 NS
§
 0.036 
Leucine -5.1
a 
-8.0
b 
-8.0
b 
0.96 0.009
 
0.020
§||
 0.008 
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Lysine -12.9
a 
-18.7
b 
-24.3
b 
2.61 0.004 0.099
§
 0.009 
Phenylalanine -10.9 -12.5 -13.3 1.39 NS NS 0.029 
Tryptophan -3.5
 
-3.6
 
-8.3
 
1.93 0.052 NS NS 
Tyrosine -9.6 -9.6 -9.4 1.19 NS NS
§
 NS 
Valine -4.0 -5.6 0.2 3.44 NS NS NS 
Urea 658
 
614
 
802
 
161.1 NS NS NS 
Ammonia -579 -456 -824 138.7 0.088 NS NS 
 
Infused AA-N 
 
Cysteine -0.8
a 
-1.8
a 
-8.7
b 
0.70 <0.001 NS 0.017 
Glutamine 3.8
a 
-38.5
b 
-78.2
c 
18.6 0.004 NS 0.003 
Methionine -3.6
a 
-4.4
a 
-11.5
b 
1.73 <0.001 NS 0.067 
Proline -5.8
a 
-8.8
b 
-14.2
c 
1.05 <0.001 0.014
§
 0.005 
Serine -12.7
a 
-15.3
a 
-37.1
b 
3.12 <0.001 NS 0.034 
Threonine -5.5
a 
-6.9
b 
-32.0
c 
0.90 <0.001 NS 0.036 
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Total AA-N -154
a 
-271
b 
-382
c 
38.4 <0.001 NS 0.001 
 
LPS lipopolysaccharide, AA amino acids infused 
 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. Where there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the 
treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡
 Only 3 sheep for the LPS+AA treatment  
 
§ 
Period x treatment interaction (P<0.05) with less uptake during Period 2 for LPS and LPS+AA.  
 
|| 
 More hepatic removal during Period 1 
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Table 6. Net total splanchnic appearances (µmol N/min) of amino acid-N in response to 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per 
min), either with or without six supplemental amino acids (AA),LPS, in 8 sheep. 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment  P 
 Saline LPS LPS+AA SED
+ 
Treatment
*
 Period
*
 LPS
†
 
Non-infused AA-N  
Alanine 6.5
a
 -11.9
b
 3.6
a
 3.93 0.006 0.005
‡
 0.030 
Arginine 8.4
a
 -20.4
b
 -2.9
ab
 10.01 0.048
¶
 NS 0.043 
Aspartate 3.7 1.5 2.2 1.09 0.084 0.060 0.013 
Glutamate 21.9 20.4 18.5 9.09 NS NS NS 
Glycine -10.6 -15.8 -14.7 5.65 NS NS NS 
Histidine -0.3 -3.1 -5.4 2.85 NS 0.070 0.083 
Isoleucine 12.9 8.1 11.3 3.17 NS 0.060 0.099 
Leucine 14.0 7.5 14.3 2.64 0.054 0.026
‡
 NS 
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Lysine 27.8 14.0 24.7 5.90 0.077 0.044
‡
 0.097 
Phenylalanine 1.5 -2.1 -0.2 1.34 0.059
 
0.059 0.071 
Tryptophan 0.1
a
 -1.1
ab
 -2.3
b
 0.67 0.010 NS 0.024 
Tyrosine 0.9 -1.2 2.3 1.22 0.073 0.022
‡
 NS 
Valine 13.5 8.0 19.3 4.27 0.096 0.066 NS 
Urea-N 399 288 440 144.7 NS NS NS 
Ammonia -32 -22 18 14.7 NS NS
§
 NS 
 
Infused AA-N 
 
Cysteine 1.1
a 
0.2
a
 6.6
b
 1.05 0.001 NS NS 
Glutamine -47.9 -53.0 -53.9 25.55 NS NS NS 
Methionine 2.8
a
 2.1
a
 5.8
b
 0.082 0.006 0.070
§
 NS 
Proline 5.1
a
 1.2
a
 11.9
b
 1.89 0.004 0.026
‡
 NS 
Serine 11.4 6.0 17.0 3.94 0.081 0.088 NS 
Threonine 8.3
a
 4.8
a
 15.2
b
 2.57 0.004 NS NS 
        
Page 38 of 43
Cambridge University Press
British Journal of Nutrition
For Review Only
39 
 
Net AA-N  79
a 
-22
b 
63
ab 
36.9 0.069 0.028
‡
 NS 
 
TSP total splanchnic release, LPS lipopolysaccharide, AA amino acids infused 
 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. Where there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the 
treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
‡ 
Values lower for Period 1 than Period. 
 
§ 
Period x treatment interaction for methionine with lower TSP (P=0.014) during Period 2 for saline infusion while values for LPS and LPS+AA infusions were 
greater. 
 
¶ 
Only 3 sheep for the LPS+AA treatment  
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Table 7. Impact of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), on irreversible loss 
rates (mmol/h) of plasma phenylalanine for the whole body (WB) and across the tissues of the splanchnic bed. 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment*  P 
 Saline LPS LPS+AA SED
+ 
Treatment
†
 Period
†
 LPS
‡
 
Whole Body
 
 2.28
a
 2.58
b
 2.74
b
 0.097 0.003 0.096
§
 <0.001 
Splanchnic tissues   
PDV -0.31 -0.35 -0.34 0.101 NS 0.047
¶ 
 NS 
Liver -0.57
a
 -0.72
ab
 -0.83
b
 0.111 0.046 NS 0.023 
TSP -0.87 -1.09 -1.15 0.167 NS NS 0.034 
Tissue:WB ratio   
PDV 0.13 0.13 0.13 0.029 NS 0.072
¶
 NS 
Liver 0.25 0.28 0.30 0.053 NS NS NS 
TSP 0.39 0.43 0.42 0.076 NS NS NS 
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WB ILR whole body irreversible loss rate (of phenylalanine), TSP total splanchnic preparation (liver + PDV); PDV, portal drained viscera (total gut) 
 
* all values based on arterial enrichments  
 
†
 Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed effects, 
where treatment was either saline, LPS, or LPS+AA infusion. There were no period x treatment effects (P>0.05). Where there was a treatment effect 
(P<0.05), post-hoc t-test was performed to compare the treatment means, where values in rows with unlike superscripts are significantly different (P<0.05). 
 
‡ 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in combination with 
AA).  
 
§ 
Values greater for Period 1 than Period 2. 
 
¶ 
Values greater for Period 2 than Period 1. 
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Supplementary Table S1 
 
Impact of a 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), 
on arterial concentrations of albumin, total protein, glucose, lactate and lymphocytes in 11 sheep. 
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 treatment  P 
 Control LPS LPSAA SED Treatment* Period* LPS
†
 
Albumin (g/l) 27.3
 
26.3
 
25.9
 
1.10 NS NS NS 
Protein (g/l) 61.9 60.9 59.3 2.35 NS NS NS 
Glucose (mM)
¶
 4.12
 
 2.78 3.27 0.487 0.019 NS 0.006 
Lactate (mM) 1.34 1.13 1.38 0.428 NS NS NS 
Lymphocytes
 
(10
9
 
cells/l)
 ‡
 
4.33
a
 12.82
b
 9.67
b
 1.917 <0.001 NS <0.001 
 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed 
effects, where treatment was either saline, LPS (n=6), or LPS+AA (n=5) infusion. There were no period x treatment effects (P>0.05). Where 
there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the treatment means, where values in rows with unlike 
superscripts are significantly different (P<0.05). 
 
† 
Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in 
combination with AA).  
 
‡
 One missing value (for LPS treatment) 
 
  
Page 42 of 43
Cambridge University Press
British Journal of Nutrition
For Review Only
Supplementary Table S2 
 
Effect of 20 h infusion of saline or lipopolysaccharide (LPS; 2 ng/kg LW per min), either with or without six supplemental amino acids (AA), on 
synthesis rates of plasma albumin, total plasma protein and lymphocytes in 11 sheep  
(Predicted means with the standard errors of the difference (SED) between means for the effect of treatment) 
 
 
 treatment  P 
 Saline
 
LPS
 
LPS+AA SED Treatment
* 
Period
* 
LPS status
†
 
Albumin 
  FSR (%/d) 
  ASR (g/d) 
 
4.67
a 
2.92
a
 
 
2.00
b
 
1.35
b
 
 
2.77
b
 
1.38
b
 
 
0.634 
0.412 
 
<0.001 
<0.001 
 
NS 
NS 
 
<0.001 
<0.001 
Total protein 
  FSR (%/d) 
  ASR (g/d)
  
 
11.4
a
 
15.2
a
 
 
16.2
b
 
19.2
b
 
 
15.1
b
 
21.2
b
 
 
1.31 
1.72 
 
<0.001 
0.006 
 
0.020
‡
 
0.012
‡
 
 
<0.001
‡
 
0.002
‡
 
Lymphocytes 
FSR (%/d) 
ASR (mg/d)
 §
  
 
6.33
a
 
26.3
a
 
 
10.95
b
 
112.9
b
 
 
9.68
ab
 
90.5
b
 
 
2.25 
31.63 
 
0.042 
0.006 
 
0.017
‡
 
0.036
‡ 
 
0.027
‡
 
0.002
‡
 
 
LPS lipopolysaccharide, AA amino acids infused, FSR fractional synthesis rate, ASR absolute synthesis rate 
* Analysed by random effects model, with sheep and period within sheep as random effects and period, treatment plus their interaction as fixed 
effects, where treatment was either saline, LPS (n=6), or LPS+AA (n=5) infusion. There were no period x treatment effects (P>0.05). Where 
there was a treatment effect (P<0.05), post-hoc t-test was performed to compare the treatment means, where values in rows with unlike 
superscripts are significantly different (P<0.05). 
 
†
 Analysed by random effects model as described above, where treatment reflects LPS status, i.e. either saline or LPS (both alone and in 
combination with AA).  
 
‡
 Values lower during period 2. 
 
§
 One missing value (LPS). 
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